Hunan Fangsheng Pharmaceutical Co.,Ltd.’s Net Profit Rose 295.7% in 2022

Hunan Fangsheng Pharmaceutical Co.,Ltd. (湖南方盛制药股份有限公司) (603998.SH) reported a net profit of 276.7 million yuan in 2022, up 295.7% year-on-year.

Meanwhile, the company posted 1.8 billion yuan in revenue, up 14.4% year-on-year.

At the end of the reporting period, it had 2.9 billion yuan in total assets and 1.4 billion yuan in total liabilities, with a liability-to-asset ratio of 48.4%.